Lying alone, in the dark, Leigh Shulman tried willing away the blinding migraine pain that had forced her to skip meeting ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Discover how ayurveda, an ancient healing system, can help you live better with migraine. Discover doshas, dietary strategies ...

The approval of Axsome Therapeutics’ Symbravo for migraine with or without aura came alongside the greenlight for Vertex's non-opioid treatment Journavx.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

with at least eight of those days involving your usual migraine symptoms. For Botox treatment, you'll usually get around 30 small injections into key areas around your face, head, and neck.

You may have heard of nasal sprays as a potential treatment option for migraine. But what exactly are they, and how do they work? Below, we’ll answer these questions about migraine nasal sprays ...

has approved SYMBRAVO®, a novel migraine treatment for adults. SYMBRAVO, which combines meloxicam and rizatriptan, targets multiple pathways underlying a migraine attack. Clinical trials have ...